Condensed Consolidated Balance Sheet - USD ($) $ in Millions		Mar. 31, 2022	Dec. 31, 2021
Cash and cash equivalents
Noninterest-bearing		$ 470	$ 502
Interest-bearing		3,462	4,560
Total cash and cash equivalents (a)	[1]	3,932	5,062
Equity securities		869	1,102
Available-for-sale securities (amortized cost of $35,592 and $33,650)	[1]	33,385	33,587
Held-to-maturity securities (fair value of $1,106 and $1,204)		1,159	1,170
Loans held-for-sale, net		471	549
Finance receivables and loans, net
Finance receivables and loans, net of unearned income		125,365	122,268
Allowance for loan losses		(3,301)	(3,267)
Total finance receivables and loans, net		122,064	119,001
Investment in operating leases, net		10,730	10,862
Premiums receivable and other insurance assets		2,730	2,724
Other assets		8,957	8,057
Total assets		184,297	182,114
Deposit liabilities
Noninterest-bearing		175	150
Interest-bearing		142,300	141,408
Total deposit liabilities		142,475	141,558
Short-term borrowings		3,950	0
Long-term debt		15,885	17,029
Interest payable		302	210
Unearned insurance premiums and service revenue		3,500	3,514
Accrued expenses and other liabilities		2,772	2,753
Total liabilities		168,884	165,064
Contingencies (refer to Note 24)
Equity [Abstract]
Common stock and paid-in capital ($0.01 par value, shares authorized 1,100,000,000; issued 506,435,119 and 504,521,535; and outstanding 327,306,298 and 337,940,636)		21,728	21,671
Preferred stock		2,324	2,324
Accumulated deficit		(1,076)	(1,599)
Accumulated other comprehensive loss		(1,791)	(158)
Treasury stock, at cost (179,128,821 and 166,580,899 shares)		(5,772)	(5,188)
Total equity		15,413	17,050
Total liabilities and equity		$ 184,297	$ 182,114

[1] Refer to Note 7 for discussion of cash and cash equivalents and investment securities pledged as collateral.